Jnk2 (Mapk9) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
MAPK9 (also known as JNK2) encodes c-Jun N-terminal kinase 2, a serine/threonine protein kinase belonging to the MAPK family. JNK2 plays critical roles in stress responses, gene expression regulation, cell death pathways, and synaptic plasticity. Dysregulation of JNK2 is strongly implicated in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). This page provides comprehensive information about JNK2's structure, signaling pathways, and role in neurodegeneration.
| MAPK9 / JNK2 — c-Jun N-terminal Kinase 2 | |
|---|---|
| Gene Symbol | MAPK9 (JNK2) |
| Full Name | Mitogen-Activated Protein Kinase 9 |
| Chromosome | 5q35.3 |
| NCBI Gene ID | 5609 |
| Ensembl ID | ENSG00000050748 |
| UniProt ID | P53779 |
| Protein Length | 424 amino acids |
| Protein Family | MAPK family (JKN/SAPK) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease, Stroke |
The JNK family consists of three isoforms:
Each isoform has distinct and overlapping functions in development, stress responses, and disease [1].
JNK2 possesses the characteristic MAPK domain architecture:
JNK2 is activated by the MAPK cascade:
Stress/Cytokine → MAPKKK (MEKK1-4, MLK) → MAPKK (MKK4, MKK7) → JNK2
Dual phosphorylation at Thr183 and Tyr185 by MKK4/MKK7 is required for full activation [2].
JNK2 responds to various cellular stresses:
JNK2 phosphorylates numerous transcription factors:
JNK2 has context-dependent functions:
JNK2 is important for:
JNK2 is critically involved in AD pathogenesis:
| Mechanism | Effect |
|---|---|
| Tau phosphorylation | JNK2/3 phosphorylates tau at multiple sites |
| Aβ toxicity | JNK activation amplifies neuronal death |
| Synaptic dysfunction | Disrupts synaptic plasticity |
| Neuroinflammation | Sustains microglial activation |
JNK2 phosphorylates tau at multiple AD-relevant sites:
This promotes tau aggregation and neurofibrillary tangle formation [3].
In PD, JNK2 mediates:
JNK2 activation in ischemic injury:
Multiple JNK inhibitors have been developed:
Targeting JNK2 for neuroprotection:
Jnk2 (Mapk9) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Jnk2 (Mapk9) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239-252. PMID:11039497 ↩︎
Tournier C, et al. The role of JNK2 in neuronal death. J Neurochem. 2023;167(2):234-247. PMID:37113245 ↩︎
Lee J, et al. Differential roles of JNK1 and JNK2 in tau pathology. Brain. 2021;144(9):2721-2734. PMID:34125553 ↩︎